|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
DE3590766C2
(enExample)
|
1985-03-30 |
1991-01-10 |
Marc Genf/Geneve Ch Ballivet |
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
EP0478627A4
(en)
|
1989-05-16 |
1992-08-19 |
William D. Huse |
Co-expression of heteromeric receptors
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
US5183884A
(en)
|
1989-12-01 |
1993-02-02 |
United States Of America |
Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
CA2089661C
(en)
|
1990-08-29 |
2007-04-03 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
DE122004000008I1
(de)
|
1991-06-14 |
2005-06-09 |
Genentech Inc |
Humanisierter Heregulin Antikörper.
|
|
ES2227512T3
(es)
|
1991-12-02 |
2005-04-01 |
Medical Research Council |
Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
|
|
EP1291360A1
(en)
|
1991-12-13 |
2003-03-12 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US6706484B1
(en)
|
1995-08-18 |
2004-03-16 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
CA2229043C
(en)
|
1995-08-18 |
2016-06-07 |
Morphosys Gesellschaft Fur Proteinoptimierung Mbh |
Protein/(poly)peptide libraries
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
EP1728802A3
(en)
*
|
1996-03-27 |
2006-12-13 |
Genentech, Inc. |
ErbB3 antibodies
|
|
US5968511A
(en)
|
1996-03-27 |
1999-10-19 |
Genentech, Inc. |
ErbB3 antibodies
|
|
US5804968A
(en)
|
1997-01-29 |
1998-09-08 |
Picker International, Inc. |
Gradient coils with reduced eddy currents
|
|
US20030105057A1
(en)
|
1997-03-19 |
2003-06-05 |
Yale University |
Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment
|
|
DK0998486T4
(da)
|
1997-06-13 |
2012-05-14 |
Genentech Inc |
Proteinoprensning ved kromatografi efterfulgt af filtrering på en ladet fase
|
|
US6417168B1
(en)
|
1998-03-04 |
2002-07-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of treating tumors
|
|
ZA200007412B
(en)
|
1998-05-15 |
2002-03-12 |
Imclone Systems Inc |
Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases.
|
|
AUPQ105799A0
(en)
|
1999-06-18 |
1999-07-08 |
Victor Chang Cardiac Research Institute, The |
Cell growth inhibition
|
|
MXPA01013458A
(es)
|
1999-06-25 |
2002-07-30 |
Genentech Inc |
Anticuerpos humanizados anti-erbb2 y tratamiento con anticuerpos anti-erbb2.
|
|
DE60044997D1
(de)
|
1999-07-02 |
2010-11-04 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
US7390632B2
(en)
|
1999-09-30 |
2008-06-24 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 receptor isoforms
|
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
MXPA02011379A
(es)
|
2000-05-19 |
2003-06-06 |
Genentech Inc |
Ensayo de deteccion de genes para mejorar la probabilidad de una respuesta efectiva a terapia de cancer con el antagonista erbb.
|
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
DK1355919T3
(da)
|
2000-12-12 |
2011-03-14 |
Medimmune Llc |
Molekyler med længere halveringstider, sammensætninger og anvendelser deraf
|
|
EP1228766A1
(en)
|
2001-01-31 |
2002-08-07 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
PYK2 phosphorylation by HER3 induces tumor invasion
|
|
US20040138160A1
(en)
|
2001-04-27 |
2004-07-15 |
Kenichiro Naito |
Preventive/therapeutic method for cancer
|
|
WO2002087618A1
(en)
|
2001-04-27 |
2002-11-07 |
Takeda Chemical Industries, Ltd. |
Preventive/therapeutic method for cancer
|
|
US7744882B2
(en)
|
2001-05-31 |
2010-06-29 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 methods of detection and antibodies
|
|
US7638302B2
(en)
|
2001-05-31 |
2009-12-29 |
Tumor Biology Investment Group, Inc. |
Soluble ErbB3 receptor isoforms
|
|
JP4619651B2
(ja)
|
2001-06-01 |
2011-01-26 |
コーネル・リサーチ・ファンデーション・インコーポレイテッド |
前立腺特異的膜抗原に対する修飾抗体およびその使用
|
|
AU2002345673B2
(en)
|
2001-06-13 |
2007-04-26 |
Genmab A/S |
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
|
|
JP2005500034A
(ja)
|
2001-06-20 |
2005-01-06 |
プロション バイオテク リミテッド |
受容体型タンパク質チロシンキナーゼ活性化を遮断する抗体、そのスクリーニング方法、及びその使用
|
|
WO2003011897A1
(en)
|
2001-07-27 |
2003-02-13 |
The Regents Of The University Of California |
Modulation of heregulin and her3 interaction
|
|
WO2003012072A2
(en)
|
2001-08-03 |
2003-02-13 |
The Trustees Of The University Of Pennsylvania |
Monoclonal antibodies to activated erbb family members and methods of use thereof
|
|
EP1283053A1
(en)
|
2001-08-09 |
2003-02-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibitors of HER3 activity
|
|
WO2003066662A2
(en)
|
2002-02-05 |
2003-08-14 |
Genentech, Inc. |
Protein purification
|
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
PL401638A1
(pl)
|
2002-03-13 |
2013-05-27 |
Array Biopharma Inc. |
N3 alkilowane pochodne benzimidazolu jako inhibitory MEK
|
|
AU2003218600C1
(en)
|
2002-03-26 |
2009-12-17 |
Zensun (Shanghai) Science & Technology Co., Ltd. |
ERBB3 based methods and compositions for treating neoplasms
|
|
US7332580B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
AU2003265235A1
(en)
|
2002-04-26 |
2003-12-19 |
Genetech, Inc. |
Non-affinity purification of proteins
|
|
US20040229293A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
Surface receptor complexes as biomarkers
|
|
US20040229380A1
(en)
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
|
US20040229299A1
(en)
|
2002-05-21 |
2004-11-18 |
Badal M. Youssouf |
Intracellular complexes as biomarkers
|
|
US7402397B2
(en)
|
2002-05-21 |
2008-07-22 |
Monogram Biosciences, Inc. |
Detecting and profiling molecular complexes
|
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
AT413486B
(de)
|
2002-07-03 |
2006-03-15 |
Igeneon Krebs Immuntherapie |
Verwendung eines antikörpers gerichtet gegen lewis-antigene
|
|
EP2263691B1
(en)
|
2002-07-15 |
2012-08-29 |
F.Hoffmann-La Roche Ag |
Treatment of cancer with the recombinant humanized monoclonal anti-erbb2 antibody 2C4 (rhuMAb 2C4)
|
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
|
US20040096436A1
(en)
|
2002-08-02 |
2004-05-20 |
Regents Of The University Of California |
Methods for inhibiting protein kinases in cancer cells
|
|
AU2003264488A1
(en)
|
2002-09-19 |
2004-04-08 |
Orient Cancer Therapy Co., Ltd. |
Immunotherapeutic for cancer
|
|
CA2504818C
(en)
|
2002-11-07 |
2013-04-23 |
Immunogen, Inc. |
Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
|
|
US7575893B2
(en)
|
2003-01-23 |
2009-08-18 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
KR101130181B1
(ko)
|
2003-02-27 |
2012-03-28 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
인플루엔자 바이러스 감염의 치료 및 검출에 유용한 핵산분자, 폴리펩티드, 항체 및 이를 포함하는 조성물
|
|
JP4764818B2
(ja)
|
2003-04-11 |
2011-09-07 |
メディミューン,エルエルシー |
組換えil−9抗体およびその使用
|
|
TW568408U
(en)
|
2003-05-14 |
2003-12-21 |
High Tech Comp Corp |
Slide structure
|
|
JP2007500248A
(ja)
|
2003-06-09 |
2007-01-11 |
ワクサル,サムエル |
細胞外アンタゴニストおよび細胞内アンタゴニストによる受容体チロシンキナーゼの抑制方法
|
|
EP1493445A1
(en)
|
2003-07-04 |
2005-01-05 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibition of stress-induced ligand-dependent EGFR activation
|
|
DK3095793T3
(da)
|
2003-07-28 |
2020-05-25 |
Genentech Inc |
Reducering af udvaskning af protein A under en protein A-affinitetskromatografi
|
|
WO2005011607A2
(en)
|
2003-08-01 |
2005-02-10 |
Smithkline Beecham Corporation |
Treatment of cancers expressing p95 erbb2
|
|
WO2005044302A1
(en)
|
2003-11-06 |
2005-05-19 |
Pfizer Products Inc. |
Selective erbb2 inhibitor/anti-erbb antibody combinations in the treatment of cancer
|
|
WO2005075514A2
(en)
|
2004-03-10 |
2005-08-18 |
Lonza Ltd. |
Method for producing antibodies
|
|
WO2005099756A2
(en)
|
2004-04-08 |
2005-10-27 |
Agus David B |
ErbB ANTAGONISTS FOR PAIN THERAPY
|
|
CN1997382A
(zh)
|
2004-05-05 |
2007-07-11 |
梅里麦克制药股份有限公司 |
调节生物活性的双特异性结合剂
|
|
AU2005279347A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
US20080206231A1
(en)
|
2004-10-05 |
2008-08-28 |
Oregon Health And Science University |
Compositions and Methods for Treating Disease
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US20070009972A1
(en)
|
2005-02-16 |
2007-01-11 |
Ginger Chao |
Epidermal growth factor receptor polypeptides and antibodies
|
|
MY152164A
(en)
|
2005-02-23 |
2014-08-15 |
Genentech Inc |
Extending time to disease progression or survival in cancer patients
|
|
BRPI0608300A2
(pt)
|
2005-03-07 |
2009-12-08 |
Targeted Molecular Diagnostics Llc |
composições inibidoras da tirosina quinase e métodos para a fabricação e uso destas composições no tratamento de doenças
|
|
WO2006133460A2
(en)
|
2005-06-09 |
2006-12-14 |
Yale University |
Methods for diagnosing and treating breast cancer based on a her/er ratio
|
|
PE20070207A1
(es)
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
|
CN101309933A
(zh)
*
|
2005-09-07 |
2008-11-19 |
米迪缪尼有限公司 |
毒素偶联的Eph受体抗体
|
|
CA2621502A1
(en)
*
|
2005-09-07 |
2007-03-15 |
Medimmune, Inc. |
Toxin conjugated eph receptor antibodies
|
|
TWI405756B
(zh)
|
2005-12-21 |
2013-08-21 |
Array Biopharma Inc |
新穎硫酸氫鹽
|
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
EP1968579A1
(en)
|
2005-12-30 |
2008-09-17 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
EP2049568A2
(en)
|
2006-04-07 |
2009-04-22 |
Københavns Universitet |
Erbb receptor-derived peptide fragments
|
|
CA2639070A1
(en)
|
2006-04-13 |
2007-11-01 |
Oncomethylime Sciences S.A. |
Novel tumour suppressor
|
|
CA2670315A1
(en)
|
2006-11-21 |
2008-11-20 |
The Regents Of The University Of California |
Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
|
|
AU2007324868B2
(en)
|
2006-11-28 |
2014-03-20 |
Daiichi Sankyo Europe Gmbh |
Activated HER3 as a marker for predicting therapeutic efficacy
|
|
WO2008140603A2
(en)
|
2006-12-08 |
2008-11-20 |
Macrogenics, Inc. |
METHODS FOR THE TREATMENT OF DISEASE USING IMMUNOGLOBULINS HAVING FC REGIONS WITH ALTERED AFFINITIES FOR FCγR ACTIVATING AND FCγR INHIBITING
|
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US7825127B2
(en)
|
2006-12-28 |
2010-11-02 |
Takeda Pharmaceutical Company, Limited |
Method for treating cancer
|
|
WO2008081331A2
(en)
|
2006-12-29 |
2008-07-10 |
Sinomab Bioscience Limited |
Enhancing the level of antibody expression by framework re-engineering
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
BRPI0808055A2
(pt)
|
2007-02-16 |
2013-07-30 |
Merrimack Pharmaceuticals Inc |
anticorpo monoclonal isolado ou porÇço do mesmo que se liga ao antÍgeno, composiÇço, Ácido nucleico isolado, vetor de expressço, cÉlula hospedeira, hibridoma, kit, uso de um anticorpo monoclonal isolado ou porÇço do mesmo que se liga ao antÍgeno, mÉtodo para diagnosticar um cÂncer associado com erbb3 em um paciente, e, anticorpo
|
|
KR20150039212A
(ko)
|
2007-03-02 |
2015-04-09 |
제넨테크, 인크. |
낮은 her3 발현을 기초로 한 her 이량체화 억제제에 대한 반응 예측
|
|
US9155753B2
(en)
|
2007-03-09 |
2015-10-13 |
Geron Corporation |
Treatment of carcinomas with a combination of EGF-pathway and telomerase inhibitors
|
|
CA2681974C
(en)
|
2007-03-29 |
2019-12-31 |
Genmab A/S |
Bispecific antibodies and methods for production thereof
|
|
EP2851091B1
(en)
|
2007-04-13 |
2017-12-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer resistant to ERBB therapeutics
|
|
US20090258005A1
(en)
|
2007-05-29 |
2009-10-15 |
Trubion Pharmaceuticals Inc. |
Therapeutic compositions and methods
|
|
EP2205277B1
(en)
|
2007-10-22 |
2017-07-26 |
Genmab A/S |
Novel antibody therapies
|
|
EP2215125A1
(en)
*
|
2007-11-27 |
2010-08-11 |
Ablynx N.V. |
Method for obtaining polypeptide constructs comprising two or more single domain antibodies
|
|
WO2009092014A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
US20110027296A1
(en)
|
2008-04-09 |
2011-02-03 |
Universidad De Barcelona |
Antibodies for treating cancer
|
|
EA022201B1
(ru)
|
2008-04-11 |
2015-11-30 |
Мерримак Фармасьютикалз, Инк. |
Агент, способный связываться с опухолевой клеткой, содержащий линкер на основе hsa, и его применение
|
|
WO2009157919A1
(en)
|
2008-06-23 |
2009-12-30 |
Tumor Biology Investment Group, Inc. |
SOLUBLE ErbB3 DETECTION, REGULATION AND TREATMENT OF CANCER
|
|
EP2138511A1
(en)
*
|
2008-06-27 |
2009-12-30 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
HER3 as a determinant for the prognosis of melanoma
|
|
EP2159836B1
(en)
|
2008-08-25 |
2017-05-31 |
Soitec |
Stiffening layers for the relaxation of strained layers
|
|
EA201170660A1
(ru)
|
2008-11-07 |
2011-12-30 |
Сантарис Фарма А/С |
Избирательная для erbb-3 (her3) комбинированная терапия
|
|
US20110020327A1
(en)
|
2008-12-16 |
2011-01-27 |
Millipore Corporation |
Purification of proteins
|
|
WO2010097186A1
(en)
|
2009-02-24 |
2010-09-02 |
Roche Diagnostic Gmbh |
Use of s-erbb-3 as a marker for cancer
|
|
NZ594665A
(en)
|
2009-03-20 |
2013-08-30 |
Genentech Inc |
Bispecific anti-her antibodies
|
|
EP2424567B1
(en)
|
2009-04-27 |
2018-11-21 |
OncoMed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
|
CA2759792A1
(en)
|
2009-04-29 |
2010-11-04 |
Trellis Bioscience, Inc. |
Improved antibodies immunoreactive with heregulin-coupled her3
|
|
WO2011001276A1
(en)
|
2009-06-30 |
2011-01-06 |
Philogen S.P.A. |
Immunocytokines in combination with anti-erbb antibodies for the treatment of cancer
|
|
WO2011019620A1
(en)
|
2009-08-10 |
2011-02-17 |
Genentech, Inc. |
Antibodies with enhanced adcc function
|
|
EP2486052A4
(en)
*
|
2009-10-09 |
2013-05-01 |
Merck Sharp & Dohme |
GENERATION, LABELING AND USE OF ANTI-HER3 ANTIBODIES
|
|
AU2010306774A1
(en)
|
2009-10-14 |
2012-05-03 |
Merrimack Pharmaceuticals, Inc. |
Bispecific binding agents targeting IGF-1R and ErbB3 signalling and uses thereof
|
|
LT2719708T
(lt)
|
2009-11-13 |
2018-02-12 |
Daiichi Sankyo Europe Gmbh |
Medžiaga ir būdai, skirti su her-3 susijusių ligų gydymui arba prevencijai
|
|
MX2012007340A
(es)
|
2009-12-22 |
2012-08-01 |
Roche Glycart Ag |
Anticuerpos anti/her3 y usos de los mismos.
|
|
PL2544680T3
(pl)
|
2010-03-11 |
2015-08-31 |
Merrimack Pharmaceuticals Inc |
Zastosowanie inhibitorów ERBB1 w leczeniu potrójnie ujemnego raka gruczołu sutkowego
|
|
CN105968206B
(zh)
|
2010-04-09 |
2020-01-17 |
Aveo制药公司 |
抗erbb3抗体
|
|
WO2011153383A1
(en)
|
2010-06-04 |
2011-12-08 |
Bipar Science, Inc. |
Methods of treating platinum-resistant recurrent ovarian cancer with 4-iodo-3-nitrobenzamide in combination with an anti-metabolite and a platinum compound
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
US20120156130A1
(en)
|
2010-08-06 |
2012-06-21 |
Thore Hettmann |
Use of her3 binding agents in prostate treatment
|
|
MY162825A
(en)
|
2010-08-20 |
2017-07-31 |
Novartis Ag |
Antibodies for epidermal growth factor receptor 3 (her3)
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
CN103189392B
(zh)
|
2010-10-18 |
2016-03-30 |
米迪亚制药有限责任公司 |
ErbB3结合抗体
|
|
KR101862832B1
(ko)
|
2010-11-01 |
2018-05-30 |
심포젠 에이/에스 |
Pan―her 항체 조성물
|
|
CA2828043A1
(en)
|
2011-03-15 |
2012-09-20 |
Merrimack Pharmaceuticals, Inc. |
Overcoming resistance to erbb pathway inhibitors
|
|
JPWO2012176779A1
(ja)
|
2011-06-20 |
2015-02-23 |
協和発酵キリン株式会社 |
抗erbB3抗体
|
|
ES2694153T3
(es)
|
2011-09-30 |
2018-12-18 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos anti-ErbB3 y usos de los mismos
|
|
WO2013071058A1
(en)
|
2011-11-09 |
2013-05-16 |
The Uab Research Foundation |
Her3 antibodies and uses thereof
|
|
EP3608340A1
(en)
|
2011-11-23 |
2020-02-12 |
Medlmmune, LLC |
Binding molecules specific for her3 and uses thereof
|
|
WO2013084147A2
(en)
|
2011-12-05 |
2013-06-13 |
Novartis Ag |
Antibodies for epidermal growth factor receptor 3 (her3)
|
|
ES2762873T3
(es)
|
2012-03-29 |
2020-05-26 |
Translate Bio Inc |
Lípidos catiónicos ionizables
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
WO2015048008A2
(en)
*
|
2013-09-24 |
2015-04-02 |
Medimmune, Llc |
Binding molecules specific for her3 and uses thereof
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
WO2015157634A1
(en)
|
2014-04-11 |
2015-10-15 |
Kolltan Pharmaceuticals, Inc. |
Anti-erbb antibodies and methods of use thereof
|
|
US20170190788A1
(en)
|
2014-09-11 |
2017-07-06 |
Bulldog Pharmaceuticals, Inc. |
Uses of anti-her3 antibodies for treating cancer
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|